FREE Account Opening + No Clearing Fees
Loading...

Remus Pharmaceuticals IPO vs Spectrum Talent Management IPO

Comparision between Remus Pharmaceuticals IPO and Spectrum Talent Management IPO.

IPO Details

Remus Pharmaceuticals IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Spectrum Talent Management IPO is a SME Book Built Issue proposed to list at NSE SME.

  Remus Pharmaceuticals IPO Spectrum Talent Management IPO
Logo Remus Pharmaceuticals IPO Logo Spectrum Talent Management IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Beeline Capital Advisors Pvt Ltd Sarthi Capital Advisors Private Limited
Registrar Link Intime India Private Ltd Skyline Financial Services Private Ltd
Market Maker Sunflower Broking Private Limited Rikhav Securities Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Remus Pharmaceuticals IPO is up to ₹47.69 Cr whereas the issue size of the Spectrum Talent Management IPO is up to ₹105.14 Cr. The final issue price of Remus Pharmaceuticals IPO is ₹1,229.00 per share and of Spectrum Talent Management IPO is ₹173.00 per share.

  Remus Pharmaceuticals IPO Spectrum Talent Management IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹1,150.00 per share ₹169.00 per share
Issue Price (Upper) ₹1,229.00 per share ₹173.00 per share
Issue Price (Final) ₹1,229.00 per share ₹173.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 100 shares 800 shares
Fresh Issue Size 3,88,000 shares 51,85,600 shares
Fresh Issue Size (Amount) up to ₹47.69 Cr up to ₹89.71 Cr
OFS Issue Size 8,92,000 shares
OFS Issue Size (Amount) up to ₹15.43 Cr
Issue Size Total 3,88,000 shares 60,77,600 shares
Issue Size Total (Amount) up to ₹47.69 Cr up to ₹105.14 Cr

IPO Timetable

Remus Pharmaceuticals IPO opens on May 17, 2023, while Spectrum Talent Management IPO opens on Jun 09, 2023. The closing date of Remus Pharmaceuticals IPO and Spectrum Talent Management IPO is May 19, 2023, and Jun 14, 2023, respectively.

  Remus Pharmaceuticals IPO Spectrum Talent Management IPO
Anchor Bid Date May 16, 2023
Issue Open May 17, 2023 Jun 09, 2023
Issue Close May 19, 2023 Jun 14, 2023
Basis Of Allotment (Tentative) May 24, 2023 Jun 19, 2023
Initiation of Refunds (Tentative) May 25, 2023 Jun 20, 2023
Credit of Share (Tentative) May 26, 2023 Jun 21, 2023
Listing date (Tentative) May 29, 2023 Jun 22, 2023
Anchor Lockin End date 1 Jun 23, 2023 Jul 19, 2023
Anchor Lockin End date 2 Aug 22, 2023 Sep 17, 2023

Financials

Remus Pharmaceuticals IPO P/E ratio is 21.09, as compared to Spectrum Talent Management IPO P/E ratio of 15.

  Remus Pharmaceuticals IPO Spectrum Talent Management IPO
Financial
Remus Pharmaceuticals Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20530.361,276.8981.16202.03201.0335.93
31-Mar-211,104.961,922.45102.58304.61303.6127.89
31-Mar-221,590.932,543.71338.57643.17543.1719.17
31-Dec-223,352.963,361.20643.901,712.071,603.57947.45
Amount in ₹ Lakhs
Spectrum Talent Management Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-204,081.1032,362.37675.961,500.361,025.36422.19
31-Mar-214,630.2030,296.00476.411,976.301,026.3060.72
31-Mar-226,479.2948,372.171,552.712,827.371,972.371,026.88
31-Dec-228,657.6658,415.741,997.464,844.573,053.82255.09
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 92.82% 100.00%
Promoter Shareholding (Post-Issue) 68.37% 72.25%
P/E Ratio 21.09 15
Market Cap ₹181.03 Cr.
ROE 71.44%%
ROCE 69.99%%
Debt/Equity 0.03
EPS ₹33.86 ₹10.25
RoNW 52.64%% 42.99%%

Shares Offered

In the Remus Pharmaceuticals IPO retail investors (RII) are offered 97,125 shares while in Spectrum Talent Management IPO retail investors are offered 97,125 shares. Qualified institutional buyers (QIB) are offered 1,38,750 shares in Remus Pharmaceuticals IPO and 5,76,000 shares in Spectrum Talent Management IPO.

  Remus Pharmaceuticals IPO Spectrum Talent Management IPO
Anchor Investor Reserveration 1,10,500 shares
Market Maker Reserveration 19,500 shares 3,04,000 shares
QIB 1,38,750 shares 5,76,000 shares
NII 41,625 shares 25,98,400 shares
RII 97,125 shares 25,99,200 shares
Employee 0 shares 0 shares
Others
Total 2,77,500 shares 57,73,600 shares

Bids Received (Subscription)

Remus Pharmaceuticals IPO subscribed 57.21x in total, whereas Spectrum Talent Management IPO subscribed 12.27x.

  Remus Pharmaceuticals IPO Spectrum Talent Management IPO
QIB (times) 10.75x 11.21x
NII (times) 229.31x 11.68x
Big NII (times)
Small NII (times)
RII (times) 49.81x 13.10x
Employee (times)
Other (times)
Total (times) 57.21x 12.27x

Comments

Add a public comment...